Analysis of genomic targets reveals complex functions of MYC

Nature Reviews Cancer

Volumn 4, Issue 7, 2004, Pages 562-568

  Patel, Jagruti H ^a   Loboda, Andrey P ^a   Showe, Michael K ^a   Showe, Louise C ^a   McMahon, Steven B ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CARCINOGENESIS; CELL FUNCTION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENOMICS; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SYSTEMATIC REVIEW; TRANSCRIPTION REGULATION;

EID: 3042781552     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1393     Document Type: Review

References (72)

1. Dalla-Favera, R. et al. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitts lymphoma cells. Proc. Natl Acad. Sci. USA 79, 7824-7827 (1982).
2. Taub, R. et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl Acad. Sci. USA 79, 7837-7841 (1982).
3. Nesbit, C. E., Tersak, J. M. & Prochownik, E. V. MYC oncogenes and human neoplastic disease. Oncogene 18, 3004-3016 (1999).
4. Blackwood, E. M. & Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217 (1991).
5. Blackwood, E. M., Kretzner, L. & Eisenman, R. N. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev. 2, 227-235 (1992).
6. Blackwood, E. M., Luscher, B. & Eisenman, R. N. Myc and max associate in-vivo. Genes Dev. 6, 71-80 (1992).
7. Prendergast, G. C., Lawa, D. & Ziff, E. B. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65, 395-407 (1991).
8. Blackwell, T. K. et al. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13, 5216-5224 (1993).
9. Oster, S. K., Ho, C. S., Soucie, E. L. & Penn, L. Z. The myc oncogene: MarvelouslY Complex. Adv. Cancer Res. 84, 81-154 (2002).
10. Tokino, T. & Nakamura, Y. The role of p53-target genes in human cancer. Crit. Rev. Oncol. Hematol. 33, 1-6 (2000).
11. Yu, J. & Zhang, L. No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell 4, 248-249 (2003).
12. Ohtani, K. Implication of transcription factor E2F in regulation of DNA replication. Front. Biosci. 4, D793-D804 (1999).
13. Berns, K., Hijmans, E. M., Koh, E., Daley, G. Q. & Bernards, R. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19, 3330-3334 (2000).
14. Nikiforov, M. A. et al. A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell. Biol. 22, 5793-5800 (2002).
15. Lewis, B. C. et al. Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. Cancer Res. 80, 6178-6183 (2000).
16. Iritani, B. M. & Eisenman, R. N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl Acad. Sci. USA 96, 13180-13185 (1999).
17. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N. & Gallant, P. Drosophila myc regulates cellular growth during development. Cell 98, 779-790 (1999).
18. Schuhmacher, M. et al. Control of cell growth by c-Myc in the absence of cell division. Curr. Biol. 9, 1255-1258 (1999).
19. Conlon, I. & Raff, M. Size control in animal development. Cell 96, 235-244 (1999).
20. Eisenman, R. N. The Max network: coordinated transcriptional regulation of cell growth and proliferation. Harvey Lect. 96, 1-32 (2000).
21. Li, Z. et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl Acad. Sci. USA 100, 8164-8169 (2003).
22. Mao, D. Y. et al. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13, 882-886 (2003).
23. Fernandez, P. C. et al. Genomic targets of the human c-Myc protein. Genes Dev. 17, 1115-1129 (2003).
24. Orian, A. et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17, 1101-1114 (2003).
25. Sheiness, D. & Bishop, J. M. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J. Virol. 31, 514-521 (1979).
26. Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533-538 (1985).
27. Land, H., Parada, L. F. & Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983).
28. Prendergast, G. C. & Ziff, E. B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251, 186-189 (1991).
29. Kato, G. J., Barrett, J., Villa-Garcia, M. & Dang, C. V. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10, 5914-5920 (1990).
30. Kim, S. Y. Herbst, A., Tworkowski, K. A., Salghetti, S. E. & Tansey, W. P. Skp2 regulates Myc protein stability and activity. Mol. Cell 11, 1177-1188 (2003).
31. von der Lehr, N. et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol. Cell 11, 1189-1200 (2003).
32. Hateboer, G. et al. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc. Natl Acad. Sci. USA 90, 8489-8493 (1993).
33. McMahon, S. B., VanBuskirk, H. A., Dugan, K. A., Copeland, T. D. & Cole, M. D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374 (1998).
34. McMahon, S. B., Wood, M. A. & Cole, M. D. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20, 556-562 (2000).
35. Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699 (2000).
36. Ayer, D. E., Lawrence, Q. A. & Eisenman, R. N. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776 (1995).
37. Ayer, D. E., Kretzner, L. & Eisenman, R. N. Mad: a heterodimeric partner for max that antagonizes myc transcriptional activity. Cell 72, 211-222 (1993).
38. Hurlin, P. J., Queva, C. & Eisenman, R. N. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11, 44-58 (1997).
39. Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L. & Ayer, D. E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347 (1997).
40. Zeller, K. I., Jegga, A. G., Aronow, B. J., O'Donnell, K. A. & Dang, C. V. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 4, R69 (2003).
41. INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3, 392-399 (2001).
42. CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22, 351-360 (2003).
43. Luo, Q., Li, J., Cenkd, B. & Kretzner, L. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product. Oncogene 23, 1088-1097 (2004).
44. Izumi, H. et al. Mechanism for the transcriptional repression by c-Myc on PDGFβ-receptor. J. Cell Sci. 114, 1533-1544 (2001).
45. Dang C. V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19, 1-11 (1999).
46. Guo, Q, M. et al. Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res. 60, 5922-5928 (2000).
47. Schuhmacher, M. et al. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29, 397-406 (2001).
48. Neiman, P. E. et al. Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius. Proc, Natl. Acad. Sci. USA 98, 6378-6383 (2001).
49. Nesbit, G. E. et al. Genetic dissection of c-myc apoptotic pathways. Oncogene 19, 3200-3212 (2000).
50. Coller, H. A. et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates ganes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl Acad. Sci. USA 97, 3260-3265 (2000).
51. Kim, S., Zeller, K., Dang, C. V., Sandgren, E. P. & Lee, L. A. A strategy to identify differentially expressed genes using representational difference analysis and cDNA arrays. Anal. Biochem. 288, 141-148 (2001).
52. Boon, K. et al. N-myc enhances the expression of a large set of genes functioning in dbosome biogenesis and protein synthesis. EMBO J. 20, 1383-1393 (2001).
53. O'Connell, B. C. et al. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. 278, 12563-12573 (2003).
54. Schuldiner, O., Shor, S. & Benvenisty, N. A computerized database-scan to identify c-MYC targets. Gene 292, 91-99 (2002).
55. Louro, I. D. et al. Comparative gene expression profile analysis of GU and c-MYC in an epithelial model of malignant transformation. Cancer Res. 62, 5867-5873 (2002).
56. Watson, J. D., Oster, S. K., Shago, M. Khosravi, F. & Penn, L. Z. Identifying genes regulated in a Myc-dependent manner. J. Biol. Chem. 277, 36921-36930 (2002).
57. Menssen, A. & Hermeking, H. Characterization of the c-MYC-regulated transcdptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl Acad. Sci. USA 99, 6274-6279 (2002).
58. Yu, Q., He, M., Lee, N. H. & Liu, E. T. Identification of Myc-mediated death response pathways by microarray analysis. J. Biol. Chem. 277, 13059-13066 (2002).
59. Mai, S. & Mushinski, J. F. c-Myc-induced genomic instability. J. Environ. Pathol. Toxicol. Oncol. 22, 179-199 (2003).
60. Felsher, D. W. & Bishop, J. M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl Acad. Sci. USA 96, 3940-3944 (1999).
61. Eilers, M., Picard, D., Yamamato, K. R. & Bishop, J. M. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340, 66-68 (1989).
62. Cheng, S. W. et al. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nature Genet. 22, 102-105 (1999).
63. Frank, S. R. et al. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4, 575-580 (2003).
64. Eberhardy, S. R. & Farnham, P. J. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277, 40156-40162 (2002).
65. Eisenman, R. N. Deconstructing myc. Genes Dev 15, 2023-2030 (2001).
66. Herold, S. et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol. Cell 10, 509-521 (2002).
67. Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419, 729-734 (2002).
68. Gartel, A. L. & Shchors, K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp. Cell Res. 283, 17-21 (2003).
69. Wanzel, M., Herold, S. & Ellers, M. Transcriptional repression by Myc. Trends Cell Biol. 13, 146-150 (2003).
70. INK4b. Nature Cell Biol. 3, 400-408 (2001).
71. Nakamura, Y. Isolation of p53-target genes and their functional analysis. Cancer Sci. 95, 7-11 (2004).
72. Bell, L.A. & Ryan, K. M. Life and death decisions by E2F-1. Cell Death Differ. 11, 137-142 (2004).